Table 5.

Comparison of outcomes of following active surveillance or immediate radical prostatectomy. Outcomes are based on 1 million simulated patients.

	Immediate RP	Active surveillance
Treated	100.00%	63.68%
Treated with Gleason score ≤ 6	100.00%	40.69%
Treated with Gleason score 7	0.00%	19.76%
Treated with Gleason score ≥ 8	0.00%	3.23%
Time to treatment
≤ 3 years	–	27.75%
> 3 years	–	35.93%
PSA at treatment (ng/mL)
0–2.5	14.43%	14.55%
2.51–4.0	14.05%	13.73%
4.1–6.0	43.23%	30.09%
6.1–10.0	28.29%	30.42%
> 10.0	0.00%	11.21%
Cumulative incidence of recurrence from diagnosis
20-year	24.54%	31.13%
Lifetime	29.38%	37.61%
Cumulative incidence of prostate cancer death
20-year	1.64%	2.78%
Lifetime	2.00%	3.40%
Cumulative incidence of other cause death
20-year	51.60%	51.13%
Lifetime	98.00%	96.60%
Years of life per person from treatment	19.66	13.30
Total years of life per person from diagnosis	19.66	19.50
Years of life per person lost due to prostate cancer	0.25	0.40